EUVIMEDEUVIMED entdecken
Crossref

Multifunctional Antibody-drug-nanoparticle Conjugates for precision Cancer Therapy

Bo Ren, You Yang, Yuanlin Gan, Jing Wu, Charngchoon Wong

Journal of Disease and Public Health · 15.11.2025 · 2 (1) · 22-34

DOI: 10.71052/jdph/lllx6280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Disease and Public Health, online erschienen am 15.11.2025. Verfasst von Bo Ren und 4 weiteren Autor:innen. Die Arbeit nennt 71 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer medicine has stepped into the era of multidisciplinary treatments, calling for synergistic therapeutic regimens. Single therapeutic strategies, including chemotherapy, radiotherapy, surgical treatment, targeted therapy, and immunotherapy, are no longer sufficient to support cancer treatment. Various therapeutic systems based on Antibody-drug-nanoparticle conjugates (ADNCs) have been developed as promising strategies for more effective cancer therapy. The rapid advances in nanotechnology, molecular biology, pharmacy and immunology have driven the innovative development of actively targeted nanoparticles for safer and more effective precision cancer therapy. With excellent targeting capability, ADNCs can act as efficient drug carriers and tumor microenvironment (TME) regulators. In this review, we focus on the classification, structure, and applications of monoclonal antibodies (mAbs), as well as the conjugation between antibodies and nanocarriers. Meanwhile, we systematically summarize the latest progress in nanoparticles (NPs) as mainstream drug delivery systems, such as liposomes, nanoemulsions, dendrimers, carbon-based NPs, polymeric NPs, and metallic NPs. Furthermore, we discuss the design and optimization of ADNCs. Despite the tremendous potential of ADNCs, we also admit their shortcomings and challenges associated with their implementation and the clinical applications. This review aims to propose a novel and synergistic perspective of ADNCs in precision and personalized cancer treatment, offering patient-specific therapeutic alternatives for clinical practice.

Zitieren

APA

Ren, B., Yang, Y., Gan, Y., Wu, J., & Wong, C. (2025). Multifunctional Antibody-drug-nanoparticle Conjugates for precision Cancer Therapy. Journal of Disease and Public Health, 2(1), 22-34. https://doi.org/10.71052/jdph/lllx6280

Vancouver

Ren B, Yang Y, Gan Y, Wu J, Wong C. Multifunctional Antibody-drug-nanoparticle Conjugates for precision Cancer Therapy. Journal of Disease and Public Health. 2025;2(1):22-34. doi:10.71052/jdph/lllx6280

BibTeX
@article{Ren2025,
  author = {Ren, Bo and Yang, You and Gan, Yuanlin and Wu, Jing and Wong, Charngchoon},
  title = {Multifunctional Antibody-drug-nanoparticle Conjugates for precision Cancer Therapy},
  journal = {Journal of Disease and Public Health},
  year = {2025},
  volume = {2},
  number = {1},
  pages = {22--34},
  doi = {10.71052/jdph/lllx6280}
}
Kostenlos starten →